Font Size: a A A

Factors Affecting The Short-term Efficacy Of Catheter-directed Thrombolysis In The Treatment Of Deep Venous Thrombosis Of Lower Extremities

Posted on:2022-12-05Degree:MasterType:Thesis
Country:ChinaCandidate:L LiFull Text:PDF
GTID:2504306779481304Subject:Endocrine and Systemic Diseases
Abstract/Summary:PDF Full Text Request
Objective:To explore the factors affecting the short-term efficacy of catheter-directed thrombolysis(CDT)in the treatment of lower extremity deep venous thrombosis(DVT).Methods:A retrospective case-control study,the clinical data of 129 patients with lower extremity DVT who received CDT treatment from November 2017 to March 2021 in the First Affiliated Hospital of Bengbu Medical College were selected,including gender,age,course of disease,hypertension,diabetes,and malignant tumors,Fracture or trauma in the past month,pre-dilation of iliac vein balloon before CDT,leukocytes,platelets,fibrinogen,D-dimer,C-reactive protein,a total of 13 factors may affect the short-term efficacy of CDT.Among them,56 males and 73 females,aged(43.3±6.1)years old,were divided into two groups: recanalization(thrombectomy rate ≥ 50%)and non-canalization(thrombectomy rate < 50%)according to the CDT treatment effect.There were 57 cases in the recanalization group and 72 cases in the recanalization group.The clinical data of the two groups were analyzed by univariate,and the indicators with statistically significant differences(P<0.05)were analyzed by multivariate logistic regression.Results:there were 57 patients in non-patency group and 72 patients in recanalization group.Univariate analysis showed that there were significant differences in age,course of disease,malignant tumor,platelet,fibrinogen and iliac vein balloon pre-dilatation before CDT between the two groups.The results of multivariate logistic regression analysis showed that age(OR=2.734,95% CI: 1.115-6.704,P<0.05),course of disease(OR=18.761,95% CI: 3.861-91.157,P<0.05),fibrinogen(OR=1.518,95% CI: 1.085-2.125,P<0.05)and iliac vein balloon pre-dilatation(OR=0.167,95% CI: 0.038-0.744,P<0.05).Conclusion: Age,course of disease,fibrinogen and iliac vein balloon dilatation before CDT are independent factors affecting the short-term efficacy of catheter thrombolysis.
Keywords/Search Tags:deep venous thrombosis, catheter-directed thrombolysis, influencing factors, thrombolysis rate
PDF Full Text Request
Related items
The Catheter Thrombolysis And Peripheral Venous Thrombolysis Of Acute Lower Extremity Venous Thrombosis In The Early And Medium-term Efficacy Analysis
The Clinical Study Of Catheter-directed Thrombolysis Combined With Percutaneous Transluminal Angioplasty For Acute Lower Extremity Deep Venous Thrombosis
Comparison Of Catheter-directed Thrombolysis Versus Pharmaco-mechanical Thrombolysis For The Management Of Acute Deep Vein Thrombosis
Study Of Different Modes Of Catheter-directed Thrombolysis And Peripheral Intravenous Thrombolysis In Lower Extremity Deep Venous Thrombosis
Observation On The Efficacy Of Catheter-directed Thrombolysis And Transdorsalis Pedis Vein Thrombolysis In The Treatment Of Deep Venous Thrombosis In Inner Mongolia
Clinical Control Study Of Angio Jet Pharmacomechanical Thrombectomy Contact Catheter-directed Thrombolysis And Catheter-directed Thrombolysis Alone In The Treatment Of Acute Central Lower Extremity Deep Venous Thrombosis
Systematic Evaluation Of The Clinical Effect And Safety Of Manual Apiration Thrombectomy Combined With Catheter-directed Thrombolysis And Catheter-directed Thrombolysis In The Treatment Of Acute Lower Extremity Proximal Deep Venous Thrombosis
Clinical Control Study Of Angiojet Assisted Catheter-directed Thrombolysis Contact Catheter-directed Thrombolysis Alone In The Treatment Of Acute Lower Extremities Deep Venous Thrombosis
Urokinase Management And Medium-term Efficacy Of Endovascular Therapy For Residual Iliac Venous Stenosis In Catheter-directed Thrombolysis Therapy:A Prospective Study
10 Therapeutic Comparison Of Catheter Directed Thrombolysis And Dorsal Venous In Treatment Of Lower Extremity Deep Venous Thrombosis